Literature DB >> 21246348

[Plasmacytoid and micropapillary urothelial carcinoma: rare forms of urothelial carcinoma].

B Keck1, R Stoehr, S Wach, A Rogler, E Nolte, A Hartmann, B Wullich.   

Abstract

Plasmacytoid urothelial carcinomas (PUC) along with micropapillary urothelial carcinoma (MPC), small cell cancer, and nested-typed tumors are among the rare variations of urothelial carcinomas. The molecular characterization of PUC and MPC is currently the focus of our research on bladder cancer which we are conducting in cooperation with the Institute of Pathology in Erlangen. PUCs account for approximately 0.9% of all urothelial carcinomas. The diagnosis of these rare variants has acquired increasing importance since this may have prognostic and possibly therapeutic consequences for the patients. By analysis of 32 PUCs we were able to demonstrate the most comprehensive results available to date on the underlying molecular and clinical characteristics of these variants. Micropapillary cancers have already been described in multiple organs. Micropapillary breast cancer represent an individual entity with characteristic genomic aberrations and corresponding clinical and pathological features.

Entities:  

Mesh:

Year:  2011        PMID: 21246348     DOI: 10.1007/s00120-010-2484-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  27 in total

1.  Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases.

Authors:  Priya Nigwekar; Pheroze Tamboli; Mitual B Amin; Adeboye O Osunkoya; David Ben-Dor; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2009-03       Impact factor: 6.394

2.  Micropapillary bladder carcinoma: a clinicopathological study of 20 cases.

Authors:  S L Johansson; G Borghede; S Holmäng
Journal:  J Urol       Date:  1999-06       Impact factor: 7.450

3.  Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma.

Authors:  Tamara L Lotan; Huihui Ye; Jonathan Melamed; Xue-Ru Wu; Ie-Ming Shih; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2009-07       Impact factor: 6.394

4.  FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.

Authors:  Johanna M M van Oers; Ellen C Zwarthoff; Ishtiaq Rehman; Abdel-Rahmene Azzouzi; Olivier Cussenot; Mark Meuth; Freddie C Hamdy; James W F Catto
Journal:  Eur Urol       Date:  2008-06-13       Impact factor: 20.096

5.  Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.

Authors:  H Samaratunga; K Khoo
Journal:  Histopathology       Date:  2004-07       Impact factor: 5.087

6.  Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.

Authors:  J S Kovach; A Hartmann; H Blaszyk; J Cunningham; D Schaid; S S Sommer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

7.  Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast.

Authors:  C Marchiò; M Iravani; R Natrajan; M B Lambros; K Savage; N Tamber; K Fenwick; A Mackay; R Senetta; S Di Palma; F C Schmitt; G Bussolati; L O Ellis; A Ashworth; A Sapino; J S Reis-Filho
Journal:  J Pathol       Date:  2008-08       Impact factor: 7.996

Review 8.  [Plasmacytoid urothelial carcinoma of the urinary bladder. A study of 7 cases].

Authors:  A Gaafar; M Garmendia; E de Miguel; V Velasco; A Ugalde; F J Bilbao; G de Petris; J I López
Journal:  Actas Urol Esp       Date:  2008-09       Impact factor: 0.994

9.  The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.

Authors:  Ashish M Kamat; Jason R Gee; Colin P N Dinney; H Barton Grossman; David A Swanson; Randall E Millikan; Michelle A Detry; Tracy L Robinson; Louis L Pisters
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

10.  Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.

Authors:  Ashish M Kamat; Colin P N Dinney; Jason R Gee; H Barton Grossman; Arlene O Siefker-Radtke; Pheroze Tamboli; Michelle A Detry; Tracy L Robinson; Louis L Pisters
Journal:  Cancer       Date:  2007-07-01       Impact factor: 6.860

View more
  3 in total

1.  Metastatic plasmacytoid bladder cancer causing malignant priapism.

Authors:  Ryan Pereira; Marlon Perera; Handoo Rhee
Journal:  BMJ Case Rep       Date:  2019-07-01

2.  [Bladder cancer in focus: update 2012 of the German Bladder Cancer Association].

Authors:  B Keck; A S Merseburger; R Stöhr; S Füssel; M J Hoffmann; S Schmid; P Olbert; A Hartmann; R Nawroth
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

3.  Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy.

Authors:  Bastian Keck; Sven Wach; Robert Stoehr; Frank Kunath; Simone Bertz; Jan Lehmann; Michael Stöckle; Helge Taubert; Bernd Wullich; Arndt Hartmann
Journal:  BMC Cancer       Date:  2013-02-08       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.